Ewa LLC Purchases 81 Shares of UnitedHealth Group Incorporated $UNH

Ewa LLC boosted its position in UnitedHealth Group Incorporated (NYSE:UNH) by 8.4% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,045 shares of the healthcare conglomerate’s stock after acquiring an additional 81 shares during the quarter. Ewa LLC’s holdings in UnitedHealth Group were worth $326,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also added to or reduced their stakes in the company. Financial Management Professionals Inc. lifted its holdings in UnitedHealth Group by 0.8% during the first quarter. Financial Management Professionals Inc. now owns 2,224 shares of the healthcare conglomerate’s stock valued at $1,165,000 after purchasing an additional 17 shares in the last quarter. Retirement Planning Group LLC increased its position in UnitedHealth Group by 5.1% during the first quarter. Retirement Planning Group LLC now owns 430 shares of the healthcare conglomerate’s stock worth $225,000 after purchasing an additional 21 shares during the last quarter. Net Worth Advisory Group increased its position in UnitedHealth Group by 0.6% during the first quarter. Net Worth Advisory Group now owns 3,642 shares of the healthcare conglomerate’s stock worth $1,907,000 after purchasing an additional 21 shares during the last quarter. Bensler LLC increased its position in UnitedHealth Group by 0.3% during the first quarter. Bensler LLC now owns 6,945 shares of the healthcare conglomerate’s stock worth $3,637,000 after purchasing an additional 22 shares during the last quarter. Finally, Lakeridge Wealth Management LLC grew its holdings in shares of UnitedHealth Group by 5.8% in the first quarter. Lakeridge Wealth Management LLC now owns 420 shares of the healthcare conglomerate’s stock valued at $220,000 after purchasing an additional 23 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages recently weighed in on UNH. Truist Financial lifted their price objective on shares of UnitedHealth Group from $310.00 to $365.00 and gave the company a “buy” rating in a report on Tuesday, September 9th. Robert W. Baird reiterated an “underperform” rating and issued a $198.00 price target (down previously from $312.00) on shares of UnitedHealth Group in a research note on Thursday, July 31st. Royal Bank Of Canada decreased their price target on shares of UnitedHealth Group from $355.00 to $286.00 and set an “outperform” rating for the company in a research note on Wednesday, July 30th. Barclays boosted their price objective on shares of UnitedHealth Group from $337.00 to $352.00 and gave the stock an “overweight” rating in a research report on Thursday, September 4th. Finally, Sanford C. Bernstein boosted their price objective on shares of UnitedHealth Group from $337.00 to $379.00 and gave the stock an “outperform” rating in a research report on Friday, September 5th. Sixteen research analysts have rated the stock with a Buy rating, six have given a Hold rating and three have assigned a Sell rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $358.95.

UnitedHealth Group Price Performance

NYSE:UNH opened at $347.82 on Thursday. The firm has a market cap of $315.01 billion, a price-to-earnings ratio of 15.07, a price-to-earnings-growth ratio of 2.25 and a beta of 0.47. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The company’s 50-day moving average is $304.76 and its two-hundred day moving average is $357.57. UnitedHealth Group Incorporated has a 12-month low of $234.60 and a 12-month high of $630.73.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). The company had revenue of $111.62 billion for the quarter, compared to analysts’ expectations of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The company’s revenue was up 12.9% on a year-over-year basis. During the same quarter in the previous year, the company earned $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were given a dividend of $2.21 per share. The ex-dividend date of this dividend was Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.5%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 38.30%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.